Back to Search Start Over

First appraisal of brain pathology owing to A30P mutant alpha-synuclein.

Authors :
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) [research center]
Seidel, Kay
Schols, Ludger
Nuber, Silke
Petrasch-Parwez, Elisabeth
Gierga, Kristin
Wszolek, Zbigniew
Dickson, Dennis
Gai, Wei P.
Bornemann, Antje
Riess, Olaf
Rami, Abdelhaq
Den Dunnen, Wilfried F. A.
Deller, Thomas
Rub, Udo
Krüger, Rejko
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) [research center]
Seidel, Kay
Schols, Ludger
Nuber, Silke
Petrasch-Parwez, Elisabeth
Gierga, Kristin
Wszolek, Zbigniew
Dickson, Dennis
Gai, Wei P.
Bornemann, Antje
Riess, Olaf
Rami, Abdelhaq
Den Dunnen, Wilfried F. A.
Deller, Thomas
Rub, Udo
Krüger, Rejko
Publication Year :
2010

Abstract

Familial Parkinson disease (PD) due to the A30P mutation in the SNCA gene encoding alpha-synuclein is clinically associated with PD symptoms. In this first pathoanatomical study of the brain of an A30P mutation carrier, we observed neuronal loss in the substantia nigra, locus coeruleus, and dorsal motor vagal nucleus, as well as widespread occurrence of alpha-synuclein immunopositive Lewy bodies, Lewy neurites, and glial aggregates. Alpha-synuclein aggregates ultrastructurally resembled Lewy bodies, and biochemical analyses disclosed a significant load of insoluble alpha-synuclein, indicating neuropathological similarities between A30P disease patients and idiopathic PD, with a more severe neuropathology in A30P carriers.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1134955288
Document Type :
Electronic Resource